Efavirenz + Emtricitabine + Tenofovir DF Tablet is a once-daily fixed-dose combination used in first-line therapy for HIV-1 infection. It combines the NNRTI efavirenz with two NRTIs—emtricitabine and tenofovir disoproxil fumarate—to interrupt viral replication at multiple enzyme targets.

Mechanism of Action

Efavirenz (NNRTI) binds to and inactivates HIV reverse transcriptase. Emtricitabine and tenofovir (NRTIs) inhibit viral DNA chain elongation by competing with natural nucleotides.

Dosage & Administration

Take one tablet once daily at bedtime on an empty stomach to minimize central nervous system side effects and improve adherence. Swallow whole; do not chew or crush. ([turn0search3], [turn0search16])

Side Effects & Precautions

• Common: dizziness, insomnia, vivid or abnormal dreams, headache, nausea.
• Serious: lactic acidosis, liver toxicity, renal/bone toxicity (from TDF), psychiatric effects.
• Caution: not suitable in pregnancy (EFV is teratogenic), severe renal/hepatic impairment; monitor labs regularly. ([turn0search0], [turn0search4])

Disclaimer

This content is for product listing purposes only and is not a substitute for medical advice. Use strictly under medical supervision.

Viraday Tablet is a fixed-dose combination of Tenofovir Disoproxil Fumarate (300 mg), Emtricitabine (200 mg), and Efavirenz (600 mg) manufactured by Cipla. It’s used once daily in HIV-1 antiretroviral therapy for viral suppression and immune recovery.

Mechanism of Action

Tenofovir (ntRTI) and Emtricitabine (NRTI) block reverse transcriptase, while Efavirenz (NNRTI) binds non-competitively to the enzyme, inhibiting HIV replication at multiple sites. ([turn0search14])

Usage & Administration

Take one tablet daily on an empty stomach at bedtime. Consistent daily intake is critical to prevent resistance. Avoid crushing or chewing. ([turn0search1], [turn0search3])

Common Side Effects

Possible adverse effects include nausea, dizziness, insomnia, headache, rash, depression, vivid dreams, and fatigue. Monitor psychiatric symptoms and advise caution. ([turn0search1])

Precautions & Warnings

Efavirenz is teratogenic—avoid in pregnancy. Monitor liver and renal function regularly. Do not consume alcohol; caution if underlying psychiatric or hepatic conditions. ([turn0search1], [turn0search2])

Disclaimer

This content is for product listing purposes only and does not replace professional medical advice. Use only under medical supervision.

Tenofovir Disoproxil Fumarate 300 mg Tablet is an oral nucleotide reverse transcriptase inhibitor used in the treatment of HIV-1 and chronic hepatitis B infections, typically taken once daily as part of combination therapy.

Mechanism of Action

Tenofovir disoproxil is converted intracellularly to tenofovir, which inhibits reverse transcriptase and DNA polymerase, preventing viral replication in HIV and HBV. :contentReference[oaicite:0]{index=0}

Dosage & Administration

Recommended dose: one 300 mg tablet once daily, with or without food. :contentReference[oaicite:1]{index=1} Use in adults and children ≥12 years or ≥35 kg.

Side Effects

Common: nausea, diarrhoea, headache, dizziness. Long-term use may affect kidney function and bone mineral density. :contentReference[oaicite:2]{index=2}

Dosage Adjustments & Precautions

Use with caution in renal impairment; dosage interval adjustments may be needed. Monitor renal function. :contentReference[oaicite:3]{index=3}

Disclaimer

Provided for product listing purposes only. Not medical advice; consult a healthcare professional before use.

Alltera (Lopinavir 200 mg + Ritonavir 50 mg) Tablets is an antiretroviral medication belonging to the class of protease inhibitors. It is formulated as a fixed-dose combination to improve adherence and efficacy in HIV treatment.

Key Benefits

• Controls HIV viral replication and reduces viral load
• Boosts immune system function and CD4 counts
• Improves adherence by combining two drugs in one tablet

How It Works

Lopinavir inhibits HIV-1 protease, preventing cleavage of viral polyproteins into functional proteins. Ritonavir acts as a pharmacokinetic enhancer, increasing lopinavir plasma concentration by inhibiting CYP3A metabolism.

Dosage & Administration

Recommended dose: 2 tablets (200/50 mg) twice daily with food, or as directed by a healthcare provider. Pediatric dosing is weight-based.

Safety & Precautions

• Common side effects: diarrhea, nausea, abdominal pain, elevated lipids
• Use with caution in patients with liver disease or pancreatitis
• Potential for multiple drug–drug interactions; consult healthcare provider

Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Patients must consult a licensed physician before initiating ART.